(Source: H Lundbeck A/S) February 6, 2013 Full year report 2012 - Lundbeck delivers on guidance and sales of New Products increase more than 70% H. Lundbeck A/S (Lundbeck) announces its financial results for 2012, which are in line with expectations for the year, excluding restructuring charges. Revenue for 2012 was DKK 14,227 million,excluding Lexapro in the US, which is an increase of 6% compared with 2011. Growth was driven primarily by Lundbeck's New Products*, which generated revenue of DKK 2,141 million, an increase of 71% compared with 2011. Profits were impacted by the loss of Lexapro® revenue in the US, due to patent expiration, and EBIT for 2012 was DKK 2,177 million, excluding...
0 Responses to Full year report 2012 - Lundbeck delivers on guidance and sales of New Products increase more than 70% (H Lundbeck A/S)